ARCT - Canaccord starts Arcturus at buy; cites CF drug COVID-19 vaccine
2023-12-13 13:48:55 ET
More on Arcturus Therapeutics
- From Financial Metrics To mRNA Milestones: Arcturus Therapeutics' Evolving Journey
- Arcturus: COVID Vaccine Approval Shots In Japan And Europe Key To Unlocking Upside
- Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2023 Earnings Call Transcript
- Arcturus, CSL win approval for world’s first self-amplifying mRNA vaccine in Japan
- Arcturus cystic fibrosis therapy gets orphan drug status
For further details see:
Canaccord starts Arcturus at buy; cites CF drug, COVID-19 vaccine